* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download B CELL
Immune system wikipedia , lookup
Lymphopoiesis wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
Innate immune system wikipedia , lookup
Adaptive immune system wikipedia , lookup
Monoclonal antibody wikipedia , lookup
Molecular mimicry wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
X-linked severe combined immunodeficiency wikipedia , lookup
ACQUIRED IMMUNITY RECOGNITION ADAPTIV IMMUNITY IS TRANSFERABLE Antibodies, antibody specificity, diversity Antibodies were discovered in the late 1800s (Emil Behting, Shibasaburo Kitasato) SERUM THERAPY antibodies specific to toxins Discovery of blood group antigens (Landsteiner) QUESTION: How can so many different pathogens and other structures be recognized by antibodies? What drives and How the production of antibodies? Niels Jerne Ehrlich Paul Macferlene Burnet Macfarlane Burnet (1956 - 1960) CLONAL SELECTION THEORY What is a clone in fact? Antibodies are natural products that appear on the cell surface as receptors and selectively react with the antigen Lymphocyte receptors are variable and carry various antigen-recognizing receptors ‘Non-self’ antigens/pathogens encounter the existing lymphocyte pool (repertoire) Antigens select their matching receptors from the available lymphocyte pool, induce clonal proliferation of specific clones and these clones differentiate to antibody secreting plasma cells The clonally distributed antigen-recognizing receptors represent about ~107 – 109 distinct antigenic specificities DIVERSITY OF LYMPHOCYTES 1012 lymphocytes in our body ( B and T lymphocytes) Assumption 1 (Lamarcian) How many Assumption 2 (Darwinian) The receptor can be SPECIFICITIES All lymphocytes have activated by many ? a different receptor different antigens Cc. (minimum) 10 million various (107) B lymphocyte clones with different antigen-recognizing receptors Cc. (minimum) 10 – 1000 million various (107 - 9) T lymphocyte clones with different antigen-recognizing receptors BINDING OF ANTIGEN TO THE SELECTED B-LYMPHOCYTES RESULTS IN CLONAL EXPANSION B cell B Cell Receptor (BCR) A nti g e n Ag Plasma cell ACTIVATION Clonal expansion Differentiation Antibody (immunoglobulin Ig) secretion MEMORY B CELLS A nti g e n A nti g e n Clonal selection induces proliferation and increases effector cell frequency No. of cells with useful specificity Threshold of protective effector function No. of cell divisions POSSIBLE FATES OF B-LIMPHOCYTE CLONES Transient, not final differentiation state Activation Clonal expansion/proliferation Differentiation Memory cell Circulation Restricted life span Homeostasis Apoptosis Plasma cell Antibody production THE B-CELL ANTIGEN RECOGNIZING RECEPTOR AND ANTIBODIES PRODUCED BY PLASMA CELLS HAVE THE SAME PROTEIN STRUCTURE = IMMUNOGLOBULIN B CELL Antigen recognizing receptor BCR Immunoglobulin (Ig) Antibody TWO FORMS OF IMMUNOGLOBULINS Membrane-bound Ig Antigen-specific receptor Antigen binding L L L H H Secreted Ig Antigen-specific soluble protein EFFECTOR MOLECULE L H H ab signalling PLASMA CELL B CELL IMMUNOGLOBULIN IgG VH FV= VH+ VL VL Antigen binding site Bacteria are not well informed how to display Ag determinants for proper binding by host-antibodies host-antibodies need to be flexible TIME COURSE OF THE ADAPTIVE IMMUNE RESPONSE Antibody g/ml serum Lag Recognition Activation AFFERENT Response to antigen A Primary Response to antigen B Antigen A Days AAntigen antigénB CHARACTERISTICS OF INNATE AND ACQUIRED IMMUNITY • • • • • • • NATURAL/INNATE Rapid, prompt response (hours) No variable receptors Limited number of specificities No improvement during the response No memory Not transferable Can be exhausted, saturated • • • • • • • • ADAPTIVE/ACQUIRED Time consuming Variable antigen receptors Many very selective specificities Efficacy is improving during the response Memory Can be transferred Regulated, limited Protects self tissues COMMON EFFECTOR MECHANISMS FOR THE ELIMINATION OF PATHOGENS ORGANIZATION AND STRUCTURE OF THE IMMUNE SYSTEM ORGANIZATION AND STRUCTURE OF THE IMMUNE SYSTEM ORGANS OF THE IMMUNE SYSTEM LYMPHOID ORGANS GENERATION AND MIGRATION OF CELLS OF THE IMMUNE SYSTEM LYMPHOCYTE HOEMOSTASIS, RECIRCULATION THE ROLE OF LYMPHATICS IN THE TRANSPORTATION OF ANTIGENS INITIATION OF IMMUNE RESPONSE IN PERIPHERAL LYMPHOID ORGANS ORGANIZATION OF THE IMMUNE SYSTEM T-lymphocytes Pathogens Allergens Lymph nodes Blood circulation Lymph circulation Cellular immune response Thymus Helper Th Cytotoxic Tc Spleen PERIPHERAL SECONDARY LYMPHOID ORGANS WALDEYER RING Tonsils, adenoids Palatinal, pharyngeal lingual and tubar tonsils Antigens Nyirokerek Lymphatic vessels Bone marrow CENTRAL PRIMARY LYMPHOID ORGANS Stem cells B-lymphocytes Antibodies ORGANIZATION OF THE IMMUNE SYSTEM LYMPHOCYTES CONGREGATE IN SPECIALIZED TISSUES • CENTRAL (PRIMARY) LYMPHOID ORGANS – Bone marrow – Thymus DEVELOPMENT TO THE STAGE OF ANTIGEN RECOGNITION • PERIPHERAL (SECONDARY) LYMPHOID ORGANS – Spleen – Lymph nodes – Skin-associated lymphoid tissue (SALT) – Mucosa-associated lymphoid tissue (MALT) – Gut-associated lymphoid tissue (GALT) – Bronchial tract-associated lymphoid tissue (BALT) ACTIVATION AND DIFFERENTIATION TO EFFECTOR CELLS • BLOOD AND LYMPH CIRCULATION – Lymphatics – collect leaking plasma (interstitial fluid) in connective tissues – Lymph – cells and fluid – No pump – one way valves ensure direction – edema – Several liters (3 – 5) of lymph gets back to the blood daily – vena cava superior CENTRAL (PRIMARY) LYMPHOID ORGANS GENERATION OF BLOOD CELLS BEFORE BIRTH AFTER BIRTH Cell number (%) Yolk sac 80 Flat bones Liver 60 40 Spleen 20 Tubular bones 0 0 1 2 3 4 5 6 7 8 9 10 20 30 40 50 60 70 years months BIRTH BONE MARROW TRANSPLANTATION Őssejtek felfedezése Till és McCullogh 1960 Spleen of irradiated mouse Injected with bone marrow cells Colony forming units (CFU) THE BONE MARROW HSC cell: assymetric division 7-8000/day self renewal Stromal cell Stem cell Bone csont B-cell precursors B-precursor 2-3x108 Pre-B 2-3x107 B-cell 1-3x106 Dendritic cell 2x107 T cell precursors migrating to the thymus Central centrális sinus sinus Mature naive B-lymphocytes „Niche”-s provide the appropriate microenvironment for hematopoiesis HSC hematopoietic stem cells Entothel soluble factors(SCF, GM-CSF etc) adhesion mol. (VCAM, ICAM, E-selectin.), CXCL12 Mesenchimal cells MSC (stroma) CXCL12, nestin + cells CAR sejtek (CXCL12 abundant reticular cells) HSC maintenance fenntartása (50% HSC ha KO) Makrofágok Reg. of Osteogenesis, maintenance of HSC Adipocytes negative regulators Trabecular bone osteoblast provide growth factors and adhesion molecules Haematopoietic stem cell niches FE. Mercier Nat Rev Immunol 2012 | Immune cell niches. During B cell differentiation Biomechanical stress HSC recruitment Adamo et al., Nature 2009, North TE, et al. Cell 2009 Scheme of B Cell Development in the Bone Marrow Progenitors E n d o o s t e u m Stromal cells Pre-B X X X Macrophage Immature & mature B Central Sinus BONE MARROW HSC MYELOID PRECURSOR HEMATOPOIETIC STEM CELL LYMPHOID PRECURSOR BLOOD BLOOD DC monocyte mast neutrophil TISSUES DC THYMUS mackrophage mast neutrophil B-cell NK-cell T-cell LYMPHOID TISSUES B-cell T-cell STRUCTURE OF THE THYMUS Capsule Septum Blood circulation Epithelial cells Thymocytes Dendritic cell Macrophage Mature naive T- lymphocytes Hassal’s corpuscle STRUCTURE OF THE THYMUS THYMUS INVOLUTION 3 day-old infant 70 years old THYMUS INVOLUTION •Up to puberty/adolescence the size of the thymus is increasing and naive T lymphocytes are produced in waves to ensure protective immune responses •A sustained loss of tissue mass, cellularity and functionality of the thymus starts after puberty and lasts to middle age followed by a slower rate of involution extending to old age •DN cells do not proliferate and differentiate •Diversity of the TCR repertoire progressively becomes more limited •The thymic tissue is replaced by fat deposits •In old people naive peripheral T cells proliferate more extensively than those in younger individuals to compensate low cell numbers and reach their replicative limits earlier than in young people REDUCED RESISTANCE TO INFECTION AND TUMORIGENESIS Similar number of T cell progenitors to young individuals Limited IL-7 production, Bcl-2 expression and TCRβ rearrangement Replicative potential of thymic stromal cells is decreased The levels of nerve growth factor (NGF) secreted by medullary thymic epitelial cells (TEC) and IGF-1 produced by thymic macrophages decline